| Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies CR Gurbatri, I Lia, R Vincent, C Coker, S Castro, PM Treuting, ... Science translational medicine 12 (530), eaax0876, 2020 | 319 | 2020 |
| Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer A Harrod, J Fulton, VTM Nguyen, M Periyasamy, L Ramos-Garcia, CF Lai, ... Oncogene 36 (16), 2286-2296, 2017 | 177 | 2017 |
| Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity TM Savage, RL Vincent, SS Rae, LH Huang, A Ahn, K Pu, F Li, ... Science Advances 9 (10), eadc9436, 2023 | 29 | 2023 |
| Probiotic-guided CAR-T cells for solid tumor targeting RL Vincent, CR Gurbatri, F Li, A Vardoshvili, C Coker, J Im, ER Ballister, ... Science 382 (6667), 211-218, 2023 | 26 | 2023 |
| Probiotic-guided CAR-T cells for universal solid tumor targeting RL Vincent, CR Gurbatri, A Redenti, C Coker, N Arpaia, T Danino bioRxiv, 2021.10. 10.463366, 2021 | 8 | 2021 |
| Miniature standoff Raman probe for neurosurgical applications OAC Stevens, J Hutchings, W Gray, RL Vincent, JC Day Journal of Biomedical Optics 21 (8), 087002-087002, 2016 | 6 | 2016 |
| Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci. Transl. Med.(2020) C Gurbatri, I Lia, R Vincent, C Coker, S Castro, PM Treuting, TE Hinchliffe, ... | 5 | |
| Chimeric transmembrane proteins and uses thereof P Emtage, G Romain, R Vincent, S Wyman US Patent 11,708,401, 2023 | 4 | 2023 |
| CAR-T cells SEAK help from enzymes R Vincent, T Danino Nature Chemical Biology 18 (2), 122-123, 2022 | 4 | 2022 |
| Engineered bacteria recruit and orchestrate anti-tumor immunity TM Savage, RL Vincent, SS Rae, LH Huang, A Ahn, K Pu, F Li, C Coker, ... bioRxiv, 2022.06. 16.496462, 2022 | 2 | 2022 |
| Engineered probiotics direct the antigen specificity of CAR-T cells in situ RL Vincent, F Li, A Vardoshvili, C Gurbatri, N Arpaia, T Danino Cancer Research 84 (6_Supplement), 5237-5237, 2024 | | 2024 |
| Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells. RL Vincent, F Li, ER Ballister, N Arpaia, T Danino Journal of Visualized Experiments: Jove, 2024 | | 2024 |
| Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models RL Vincent, F Li, ER Ballister, N Arpaia, T Danino JoVE (Journal of Visualized Experiments), e65887, 2024 | | 2024 |
| Probiotic-Guided CAR-T Cells for Tumor Targeting T Danino, N Arpaia, R Vincent, T Savage, IM Jongwon, C Gurbatri US Patent App. 18/451,576, 2024 | | 2024 |
| Abstract B015: Toxin-producing bacterial therapy limits tumor growth in autochthonous mouse models of pancreatic ductal adenocarcinoma AR Decker-Farrell, SA Sastra, T Harimoto, MC Hasselluhn, F Li, R Vincent, ... Cancer Research 84 (2_Supplement), B015-B015, 2024 | | 2024 |
| Toxin-producing bacterial therapy limits tumor growth in autochthonous mouse models of pancreatic ductal adenocarcinoma AR Decker-Farrell, SA Sastra, T Harimoto, MC Hasselluhn, F Li, R Vincent, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
| Engineered bacteria direct the tumor-specificity of CAR-T cells to enable antigen-agonistic tumor targeting RL Vincent Columbia University, 2024 | | 2024 |
| Chimeric transmembrane proteins and uses thereof P Emtage, G Romain, R Vincent, S Wyman US Patent App. 18/327,651, 2023 | | 2023 |
| Probiotic neoantigen delivery vectors for precision cancer immunotherapy A Redenti, J Im, B Redenti, F Li, M Rouanne, Z Sheng, W Sun, ... bioRxiv, 2023.09. 29.560228, 2023 | | 2023 |
| proteínas transmembranares quiméricas e usos das mesmas P Emtage, G Romain, R Vincent, S Wyman | | 2021 |
